文献速递皮肤肿瘤

模拟日光与传统光动力疗法治疗轻中度光化性角化病的随机对照试验

Simulated daylight versus conventional PDT for mild to moderate actinic keratoses: A randomized controlled trial.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2026-06-10

一项单中心、非劣效性(-8%界值)随机对照试验纳入69例成人轻中度光化性角化病(AK)患者,共1458个病灶,采用分侧设计比较模拟日光光动力疗法(SDL-PDT)与常规红光光动力疗法(C-PDT)的疗效。1年清除率SDL-PDT为71.0%,C-PDT为85.3%(p<0.001),未能证明非劣效;但SDL-PDT疼痛显著更轻(平均NRS 0.8 vs 6.6,p<0.001),98.3%的受访者治疗后1天偏好SDL-PDT。

要点

  • SDL-PDT 1年清除率71.0%,低于C-PDT的85.3%,未达非劣效。
  • SDL-PDT疼痛评分显著低于C-PDT(平均NRS 0.8 vs 6.6)。
  • SDL-PDT不宜作为AK首选治疗,但可在共同决策中用于重视耐受性的患者。

核心结论

  • SDL-PDT的1年清除率低于C-PDT,但疼痛显著更轻。
  • SDL-PDT未被支持作为AK的主要治疗,但可在共同决策中考虑用于优先考虑治疗耐受性的患者。

研究设计与样本

  • 单中心、非劣效性(-8%界值)随机对照试验,纳入69例成人轻中度AK患者,共1458个病灶。
  • 采用分侧设计,同一患者受影响区域随机分配至单次C-PDT或SDL-PDT,使用5-氨基酮戊酸盐酸盐作为前药。
  • 随访在3个月评估早期治疗失败,1年评估总体清除率。

主要发现

  • 1年清除率:SDL-PDT为71.0%,C-PDT为85.3%(p<0.001),未能证明非劣效。
  • 照明期间疼痛:C-PDT平均NRS评分为6.6,SDL-PDT为0.8(p<0.001)。
  • 治疗后1天,98.3%的受访者表示偏好SDL-PDT。
  • 大多数病灶(89.9%)位于面部和头皮,通过临床和皮肤镜检查诊断。

关键数值与推荐

  • 非劣效性界值为-8%。
  • 疼痛采用0-10数字评分量表(NRS)评估。

临床怎么用

  • SDL-PDT可作为重视治疗耐受性患者的选项,但需告知其1年清除率低于C-PDT。
  • 治疗选择应基于医患共同决策,平衡长期疗效与治疗舒适度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Conventional photodynamic therapy (C-PDT) with red light is an effective but painful treatment for patients with actinic keratoses (AKs). Simulated daylight PDT (SDL-PDT) is most likely less painful, but its effectiveness has not been thoroughly investigated. OBJECTIVES: To evaluate if SDL-PDT is non-inferior to C-PDT in terms of effectiveness in the treatment of mild to moderate AKs. Additionally, pain perception, local skin reactions and patient preferences were assessed. METHODS: This single-centre, non-inferiority (-8% margin), randomized controlled trial included adults with symmetrically distributed mild to moderate AKs across one or more anatomical sites. These sites were randomly assigned to treatment with a single session of C-PDT on one half of the affected area and SDL-PDT on the other half, using 5-aminolevulinic acid hydrochloride as the prodrug. Pain during illumination was assessed using a 0-10 numeric rating scale (NRS). Patient preferences were recorded through self-report forms. Follow-up assessments were conducted at 3 months to evaluate early treatment failure and at 1 year to determine overall clearance rates. RESULTS: In total, 69 participants with 1458 mild to moderate AKs were treated. Most lesions (89.9%) were located on the face and scalp and were diagnosed through clinical and dermoscopic evaluation. After 1 year, the clearance rate was 71.0% for SDL-PDT and 85.3% for C-PDT (p < 0.001), thus failing to demonstrate non-inferiority. Illumination was reported to be more painful during C-PDT (mean NRS score of 6.6) compared with SDL-PDT (mean NRS score of 0.8) (p < 0.001). One day after treatment, 98.3% of respondents expressed a preference for SDL-PDT. CONCLUSIONS: SDL-PDT showed lower clearance rates than C-PDT but caused significantly less pain. Although not supported as a primary treatment for AKs, SDL-PDT may be considered for patients prioritizing treatment tolerability within shared decision-making. This randomized controlled trial was registered at http://www.researchweb.org/ (Project ID: 264721). UNLABELLED: WHAT IS THE DISEASE?: Actinic keratosis (AK) is a common skin condition that produces rough, scaly patches on sun‐exposed skin. Some lesions may progress to skin cancer if left untreated. LOCATION OF THE STUDY: Department of Dermatology and Venereology, Sahlgrenska University Hospital, Gothenburg, Sweden. AIM OF THE STUDY: To compare simulated daylight photodynamic therapy (SDL‐PDT) and conventional photodynamic therapy (C‐PDT) using 5‐aminolevulinic acid as the prodrug for treating mild to moderate AKs, focusing on effectiveness, pain, side effects and patient treatment preferences. METHODOLOGY: Sixty‐nine adults with mild to moderate AKs participated. Each patient received both SDL‐PDT and C‐PDT on separate halves of the affected area (split‐site design). Pain and local reactions were recorded during and after treatment, and lesion clearance was assessed at 3 months and 1 year. KEY FINDINGS: C‐PDT was more effective than SDL‐PDT with a 1‐year clearance rate of 85.3% compared to 71.0%. However, SDL‐PDT caused far less pain (mean NRS 0.8) than C‐PDT (mean NRS 6.6). Nearly all patients (98.3%) preferred SDL‐PDT immediately after treatment. CONCLUSIONS AND PRACTICAL IMPLICATIONS: SDL‐PDT is less effective but also less painful than C‐PDT. The results support person‐centred treatment decisions, helping patients and clinicians balance long‐term effectiveness and comfort when choosing therapy for AK.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Sjöholm A, Backman E, Modin M, et al. Simulated daylight versus conventional PDT for mild to moderate actinic keratoses: A randomized controlled trial. J Eur Acad Dermatol Venereol. 2026. PMID: 42266064. doi:10.1111/jdv.70556

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。